Thursday, 19 September 2019

Japan News

  • Singapore, Japan to develop eye disease detection technology

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 12 Jul, 2013

    Singapore: A*STAR's Institute for Infocomm Research (I2R), and Topcon Corporation, Japan based ophthalmic instruments and optometrics instruments manufacturer, have collaborated to develop ...Read more

  • Omron launches wireless sleep monitor in Japan

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 24 May, 2012

    Singapore: Omron Healthcare has launched a new wireless sleep monitoring device in Japan that uses ResMed's technology acquired from its recently acquired company, BiancaMed. The Omron Slee...Read more


    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2014

    Singapore: Otsuka Pharmaceutical and H Lundbeck announced the US Food and Drug Administration (FDA) has approved ABILIFY MAINTENA (aripiprazole) for extended-release injectable suspension...Read more

  • Advinus gets $36 mn research funding from Takeda

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 03 Oct, 2012

    Singapore: Takeda Pharmaceutical and Advinus Therapeutics jointly announced that they would be initiating a three-year discovery collaboration. Under the terms of the agreement, Takeda will...Read more

  • Fujifilm, Dr Reddy's terminate generics JV

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 04 Jun, 2013

    Hyderabad: Fujifilm and Dr Reddy's Laboratories have decided to terminate the memorandum of understanding (MoU) to enter into an exclusive partnership in the generic drugs business for the ...Read more

  • Takeda makes massive changes in its organization

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 26 Jun, 2013

    Singapore: Takeda Pharmaceutical announced the appointment of new senior leadership as well as the establishment of a new organization, realignment of current organizations, and change of o...Read more

  • Taiho to start ph III trial in colorectal cancer

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 31 May, 2012

    Singapore: Japan based-Taiho Pharmaceutical is starting global phase III clinical trial (RECOURSE) for the novel combination antimetabolite TAS-102 in June this year. RECOURSE is a randomi...Read more

  • Oramed gets Japanese patent for protein delivery

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 04 Apr, 2013

    Singapore: Oramed Pharmaceuticals, a developer of oral drug delivery systems, has received approval for a key patent by the Japanese Patent Office. The patent, titled "Methods and Composit...Read more

  • LG to co-develop biosimilars with Mochida

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 07 Nov, 2012

    Singapore: LG Life Sciences (LGLS) and Mochida Pharmaceutical have finalized the agreement to collaborate during the clinical trials and the registration phases of biosimilar products in ...Read more

  • Challenges that Japan pharma will face in 2014

    Japan |  Analysis | By BioSpectrum Bureau  | 0 Comment | 18 Jul, 2013

    Japan, like all other developed markets, is facing the crunch of a slowing pharma industry. Furthermore, the pharma situation is about to get worse in Japan, according to Mr Fumiyoshi Sakai...Read more

  • Fujitsu brings medical data to smartphones, iPad

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 22 Jul, 2013

    Singapore: The new mobile integrated EMR technology, developed by Fujitsu, a Japanese multinational information technology equipment and services company, now enables patients to access the...Read more

  • Chugai expands in Singapore with research institute

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 16 Jul, 2012

    Singapore: Japan's Chugai Pharmabody Research (CPR) has started its operations in Singapore. The company started operations in Singapore on July 2, 2012. The opening ceremony was attended b...Read more

  • Eisai US to replace its president, CEO

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 12 Mar, 2014

    Singapore: Eisai, US, subsidiary of Tokyo-based Eisai, has appointed Mr Yuji Matsue as chairman and chief executive officer and Mr Shaji Procida as president and chief operating officer, ef...Read more

  • François-Xavier Roge is Takeda's new CFO

    Japan |  Influencers | By BioSpectrum Bureau  | 0 Comment | 28 Aug, 2013

    Singapore: Japan-headquartered global firm, Takeda Pharmaceutical, appointed Mr François-Xavier Roger as its chief financial officer (CFO), effective September 2, 2013.In his new role, M...Read more

  • Eisai seeks nod for cancer, epilepsy drug in S Africa

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 30 Jan, 2013

    Singapore: Japan-based Eisai has filed two products, Halaven (eribulin) for metastatic breast cancer and Fycompa (perampanel) for epilepsy, for approval with Medicines Control Council (MCC)...Read more

  • Otsuka schizophrenia drug seeks EMA nod

    Japan |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 24 Dec, 2012

    Singapore: Otsuka Pharmaceutical and H Lundbeck's submission of a marketing authorization application (MAA) for the approval of aripiprazole depot formulation has been accepted by the Euro...Read more

  • Santen to give $7.9 mn fund to Clearside

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 01 Feb, 2013

    Singapore: Santen, a wholly owned subsidiary of Japan-based Santen Pharmaceuticals, and Clearside Biomedical, announced that Santen, has made an investment in Clearside Biomedical and has ...Read more

  • Takeda partners with Wipro for IT solutions

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 21 May, 2014

    Singapore: India based information technology, consulting and outsourcing company, Wipro, has partenerd with Japan's Takeda Pharmaceutical to provide IT services across the oranization. As...Read more



Survey Box

Is Pharma innovation getting inhibited in APAC?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls